The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $60.04 in the prior trading day, Nutrien Ltd (NYSE: NTR) closed at $58.02, down -3.36%. In other words, the price has decreased by -$3.36 from its previous closing price. On the day, 2.86 million shares were traded. NTR stock price reached its highest trading level at $59.91 during the session, while it also had its lowest trading level at $57.85.
Ratios:
Our goal is to gain a better understanding of NTR by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.39 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.71. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.43.
Jefferies Downgraded its Buy to Hold on July 11, 2025, while the target price for the stock was maintained at $66.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTR now has a Market Capitalization of 29056212992 and an Enterprise Value of 41454477312. As of this moment, Nutrien’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.78, and their Forward P/E ratio for the next fiscal year is 12.62. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.71. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.09 while its Price-to-Book (P/B) ratio in mrq is 1.13. Its current Enterprise Value per Revenue stands at 1.657 whereas that against EBITDA is 8.977.
Stock Price History:
The Beta on a monthly basis for NTR is 0.85, which has changed by 0.20875001 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, NTR has reached a high of $65.08, while it has fallen to a 52-week low of $43.69. The 50-Day Moving Average of the stock is 0.47%, while the 200-Day Moving Average is calculated to be 4.76%.
Shares Statistics:
The stock has traded on average 2.48M shares per day over the past 3-months and 2773330 shares per day over the last 10 days, according to various share statistics. A total of 487.49M shares are outstanding, with a floating share count of 487.14M. Insiders hold about 0.07% of the company’s shares, while institutions hold 75.82% stake in the company. Shares short for NTR as of 1759190400 were 9719336 with a Short Ratio of 3.92, compared to 1756425600 on 4039382. Therefore, it implies a Short% of Shares Outstanding of 9719336 and a Short% of Float of 2.0.
Dividends & Splits
In the trailing 12 months, NTR’s forward annual dividend rate was 2.17, compared to 2.18 this year. Against a Trailing Annual Dividend Yield of 0.036142573. The stock’s 5-year Average Dividend Yield is 3.32.
Earnings Estimates
Nutrien Ltd (NTR) is currently under the scrutiny of 16.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $0.89, with high estimates of $1.23 and low estimates of $0.72.
Analysts are recommending an EPS of between $5.15 and $4.13 for the fiscal current year, implying an average EPS of $4.57. EPS for the following year is $4.5, with 23.0 analysts recommending between $5.27 and $3.18.
Revenue Estimates
7 analysts predict $5.6B in revenue for . The current quarter. It ranges from a high estimate of $5.89B to a low estimate of $5.39B. As of . The current estimate, Nutrien Ltd’s year-ago sales were $5.08BFor the next quarter, 7 analysts are estimating revenue of $5.27B. There is a high estimate of $5.41B for the next quarter, whereas the lowest estimate is $5.16B.
A total of 16 analysts have provided revenue estimates for NTR’s current fiscal year. The highest revenue estimate was $27.26B, while the lowest revenue estimate was $25.68B, resulting in an average revenue estimate of $26.35B. In the same quarter a year ago, actual revenue was $25.02BBased on 16 analysts’ estimates, the company’s revenue will be $26.67B in the next fiscal year. The high estimate is $28.28B and the low estimate is $25.75B.
